Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MMP1 | P03956 | 8/20 | 0.56 |
| ▸ | MMP2 | P08253 | 8/20 | 0.56 |
| ▸ | MMP9 | P14780 | 8/20 | 0.56 |
| ▸ | EGFR | P00533 | 6/20 | 0.56 |
| ▸ | MAOB | P27338 | 4/20 | 0.56 |
| ▸ | MAOA | P21397 | 3/20 | 0.56 |
| ▸ | TOP2A | P11388 | 1/20 | 0.56 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.56 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.56 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.56 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.55 |
| ▸ | NAMPT | P43490 | 2/20 | 0.54 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20524931 | 0.89 | CYP3A4 (0.57) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL20524933 | 0.89 | CYP3A4 (0.57) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL20353518 | 0.87 | MEN1 (0.70) | IMPDH2NPC1RAB9ATRPV1CYP3A4 | |
| SCHEMBL20353520 | 0.87 | CYP3A4 (0.52) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL2162380 | 0.86 | CYP3A4 (0.54) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL2162386 | 0.86 | CYP3A4 (0.54) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL20353542 | 0.85 | CYP3A4 (0.58) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL2162509 | 0.84 | CYP3A4 (0.48) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL2162513 | 0.84 | CYP3A4 (0.48) | IMPDH2NPC1RAB9ATRPV1CA12 | |
| SCHEMBL14124381 | 0.83 | KDM4E (0.54) | IMPDH2NPC1RAB9ACYP3A4NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455513-B2 | Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide | AERIE PHARMACEUTICALS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| WO-2008086269-A2 | 6-AMINOISOQUINOLINE COMPOUNDS USEFUL AS KINASE MODULATORS | AERIE PHARMACEUTICALS, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| US-20080167340-A1 | 6-Aminoisoquinoline Compounds | AERIE PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167340-A1 | 6-Aminoisoquinoline Compounds | AERIE PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167340-A1 | 6-Aminoisoquinoline Compounds | COQ8A, PGC, AGK | IMPDH2 2131/4885NPC1 510/4885RAB9A 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.